Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 01 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Genetic risk factors for Clostridium difficile infection in ulcerative colitis

This month's issue of the Alimentary Pharmacology & Therapeutics evaluates genetic risk factors for Clostridium difficile infection in ulcerative colitis.

News image

Patients with inflammatory bowel disease are at higher risk for Clostridium difficile infection.

Disruption of gut microbiome and interaction with the intestinal immune system are essential mechanisms for pathogenesis of both Clostridium difficile infection and inflammatory bowel disease.

Dr Ananthakrishnan from Massachusetts, USA and fellow researchers conducted whether genetic polymorphisms associated with susceptibility to inflammatory bowel disease are also associated with risk of Clostridium difficile infection is unknown.

The team evaluated a well-characterized and genotyped cohort of patients with ulcerative colitis to identify clinical risk factors for Clostridium difficile.

The researchers examined if any of the inflammatory bowel disease genetic risk loci were associated withClostridium difficile infection, and compared the performance of predictive models using clinical and genetic risk factors in determining risk of Clostridium difficile infection.

The doctors used a prospective registry of patients from a tertiary referral hospital.

Medical record review was performed to identify all ulcerative colitis patients within the registry with a history of Clostridium difficile infection.

The genetic loci explained 28% of the variance in C difficile risk
Alimentary Pharmacology & Therapeutics

All patients were genotyped on the Immunochip.

The doctors examined the association between the 163 risk loci for inflammatory bowel disease, and risk of Clostridium difficile using a dominant genetic model.

Model performance was examined using receiver operating characteristics curves.

The study included 319 patients of whom 29 developed Clostridium difficile infection.

Female gender and pancolitis were associated with increased risk, while use of anti-TNF was protective against Clostridium difficile infection.

The researchers identified 6 genetic polymorphisms including those at TNFRSF14 that were associated with increased risk while 2 loci were inversely associated.

The research team found that none of the clinical parameters retained significance after adjusting for genetics.

Presence of at least 1 high-risk locus was associated with an increase in risk for Clostridium difficile infection.

Compared to 11% for a clinical model, the genetic loci explained 28% of the variance in Clostridium difficile risk.

Dr Ananthakrishnan's team concludes, "Host genetics may influence susceptibility to Clostridium difficile infection in patients with ulcerative colitis."

Aliment Pharmacol & Ther 2013: 38(5) 522–530
06 September 2013

Go to top of page Email this page Email this page to a colleague

 01 July 2016 
Aspirin and colorectal cancer
 01 July 2016 
Outcome measures in celiac disease
 01 July 2016 
Growth factor activity and IBD
 30 June 2016 
Staging system for familial adenomatous polyposis
 30 June 2016 
Antibiotics in children and obesity
 30 June 2016 
IBS-type symptoms in pediatric IBD
 29 June 2016 
Hep C eradication in people who inject drugs
 29 June 2016 
Anti-tumor necrosis factor in mothers and newborns
 29 June 2016 
Progression to esophageal carcinoma in Barrett's
 28 June 2016 
Gastric cancer screening in the USA
 28 June 2016 
Acute severe ulcerative colitis
 28 June 2016 
Cancer recurrence after immune-suppressive therapies
 27 June 2016 
Epidemiology of NAFLD
 27 June 2016 
Tobacco smoking and ulcerative colitis
 27 June 2016 
The Toronto Consensus for H. pylori treatment
 24 June 2016 
Statins and colorectal cancer in IBD
 24 June 2016 
Dietary trends in the USA
 24 June 2016 
Fibre for chronic idiopathic constipation
 23 June 2016 
Biomarker for eosinophilic esophagitis diagnosis
 23 June 2016 
Touch screens in the IBD outpatient clinic
 23 June 2016 
Adverse events after colonoscopy bowel preparations
 22 June 2016 
Benefits and harms of colorectal cancer screening
 22 June 2016 
IBS symptoms in IBD
 22 June 2016 
Outcomes among US veterans with Hep B
 21 June 2016 
Screening for colorectal cancer
 21 June 2016 
Tenofovir and Hep B transmission in mothers
 21 June 2016 
Access to liver subspecialty care and survival
 20 June 2016 
Genes for colorectal cancer risk
 20 June 2016 
Patients and gastroenterologists’ perceptions on IBD
 20 June 2016 
Hep C treatment in people who inject drugs
 17 June 2016 
Noninvasive markers of liver fibrosis
 17 June 2016 
Predictors of starting with long-term PPIs
 17 June 2016 
Extrahepatic manifestations of Hep C
 16 June 2016 
Assessing progression of NAFLD
 16 June 2016 
Endotracheal intubation and endoscopy unit efficiency metrics
 16 June 2016 
Bile acid diarrhea
 15 June 2016 
Consensus for acute severe ulcerative colitis
 15 June 2016 
Dental erosions in GERD
 15 June 2016 
Pharmacological treatments for obesity with weight loss
 14 June 2016 
Antibiotics and gut inflammation
 14 June 2016 
Liver-related mortality in the developed world
 14 June 2016 
Hep C patient outcomes treated with different anti-viral regimens
 13 June 2016 
Obesity in the USA
 13 June 2016 
Celiac disease drug development
 13 June 2016 
Pneumonia risk in celiac disease
 10 June 2016 

Celiac disease drug development

 10 June 2016 
Rectal cancer surgery checklist
 10 June 2016 
Breath as a marker for IBS
 09 June 2016 
Psychological morbidity in young people with IBD
 09 June 2016 
Predicting hepatic encephalopathy in cirrhosis
 09 June 2016 
Evaluation of endoscopic findings from patients with Crohn's
 08 June 2016 
Adult obesity trends in the USA
 08 June 2016 
Pediatric IBD unclassified vs other IBD
 08 June 2016 
Dark chocolate and NASH oxidation
 07 June 2016 
Flexible endoscopy for Zenker's diverticulum
 07 June 2016 
Predicting risk of hepatic encephalopathy in cirrhosis
 07 June 2016 
Electronic learning system for colon capsule endoscopy
 06 June 2016 
Disturbed sleep and symptoms in IBS
 06 June 2016 
Oral contraceptives and Crohn’s complications
 06 June 2016 
Eosinophilic esophagitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us